Cytokinetics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.About CYTK
Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.
CYTK Key Statistics
CYTK News
Analyst Jason Zemansky from Bank of America Securities maintained a Hold rating on Cytokinetics and keeping the price target at $52.00. Elevate Your Investing S...
Cytokinetics announces pricing of upsized $650M senior notes offering Sep. 17, 2025 12:25 AM ET Cytokinetics, Incorporated (CYTK) Stock By: Akanksha Khushi, SA...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
Analyst ratings
81%
of 21 ratingsMore CYTK News
Cytokinetics (CYTK) announced its intention to offer, subject to market conditions and other factors, $550M aggregate principal amount of convertible senior not...
New insider activity at Cytokinetics ( (CYTK) ) has taken place on September 15, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50...
Cytokinetics recently presented new clinical data on aficamten, its investigational treatment for hypertrophic cardiomyopathy (HCM), at the European Society of...
